skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration
This white paper from Datamonitor Healthcare identifies and discusses key highlights from the annual meeting of the European Association for the Study of the Liver (EASL), which took place in London, UK, from 9 to 13 April 2014.

Highlights in this white paper include:

 

  • ION-2, TURQUOISE-II, and COSMOS data in cirrhotic patients.
  • Phase II C-WORTHY data.
  • Phase III HALLMARK-DUAL data.
  • Patient access to expensive direct-acting antivirals.
  • Insufficiency of Gilead’s patient access schemes.




 
EASL 2014

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888-670-8900
  • US Toll           : +1 908-547-2200
  • UK & Europe : +44 (20) 337 73737
  • Australia       : +61 2 8705 6907
  • Japan            : +81 3-6273-4257

Or email us your inquiry, so we can provide you the best possible customer service:
pharma@informa.com

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: